Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic and clinicopathological value of PBRM1 expression in renal cell carcinoma.

Clinica chimica acta; international journal of clinical chemistry - 1 Nov 2018

Wang Zhun, Peng Shuanghe, Guo Linpei, Xie Hui, Wang Aixiang, Shang Zhiqun, Niu Yuanjien

Abstract excerpt

BACKGROUND: The prognostic value of PBRM1 expression in renal cell carcinoma (RCC) had been investigated in previous studies; however, the results remain inconclusive. We investigated the prognostic value and clinicopathological significance of PBRM1 protein expression in RCC. METHODS: PubMed, Embase, Web of Science, and Cochrane database were searched for studies investigating the relationships between PBRM1...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Renal Cell
Share to DNA-Binding Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to PBRM1 gene

Share to Kidney Neoplasms

Share to Mutation

Share to Nuclear Proteins

Share to Prognosis

Share to Transcription Factors

Source

Identifiers

PMID: 30006290
DOI: 10.1016/j.cca.2018.07.014

Genes

PBRM1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic and clinicopathological value of PBRM1 expression in renal cell carcinoma.PMID 30006290Read ↗

Decreased PBRM1 expression predicts unfavorable prognosis in patients with clear cell renal cell carcinomaSemantic proximity Read ↗

Prognostic and Predictive Value of PBRM1 in Clear Cell Renal Cell CarcinomaSemantic proximity Read ↗

Mutational Analysis of PBRM1 and Significance of PBRM1 Mutation in Anti-PD-1 Immunotherapy of Clear Cell Renal Cell CarcinomaSemantic proximity Read ↗

Commentary on "Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation." Kapur P, Peña-Llopis S, Christie A, Zhrebker L, Pavía-Jiménez A, Rathmell WK, Xie XJ, Brugarolas J. Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX. Lancet Oncol 2013; 14(2):159-67. [Epub 2013 Jan 16]. doi: 10.1016/S1470-2045(12)70584-3.Semantic proximity Read ↗

Significance of PBRM1 mutation in disease progress and drug selection in clear cell renal cell carcinoma.Semantic proximity Read ↗

PBRM1 and VHL expression correlate in human clear cell renal cell carcinoma with differential association with patient's overall survival.Semantic proximity Read ↗

Loss of PBRM1 expression is associated with renal cell carcinoma progression.Semantic proximity Read ↗

Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation.Semantic proximity Read ↗

PBRM1 mutation as a predictive biomarker for immunotherapy in multiple cancersSemantic proximity Read ↗

PBRM1 mutation and preliminary response to immune checkpoint blockade treatment in non-small cell lung cancerSemantic proximity Read ↗

Prognostic Significance of Hypoxia-Inducible Factor Expression in Renal Cell CarcinomaSemantic proximity Read ↗

The RBPJ/DAPK3/UBE3A signaling axis induces PBRM1 degradation to modulate the sensitivity of renal cell carcinoma to CDK4/6 inhibitorsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.